APA (7th ed.) Citation

Y, G., W, L., C, L., S, Y., M, W., K, S., . . . JS, K. (2026). Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome. Journal of autoimmunity, 161, 103563. https://doi.org/10.1016/j.jaut.2026.103563

Chicago Style (17th ed.) Citation

Y, Gan, et al. "Endothelial Cell-derived Plasminogen Activator Inhibitor-1 Potentiates Thrombosis in Antiphospholipid Syndrome." Journal of Autoimmunity 161 (2026): 103563. https://doi.org/10.1016/j.jaut.2026.103563.

MLA (9th ed.) Citation

Y, Gan, et al. "Endothelial Cell-derived Plasminogen Activator Inhibitor-1 Potentiates Thrombosis in Antiphospholipid Syndrome." Journal of Autoimmunity, vol. 161, 2026, p. 103563, https://doi.org/10.1016/j.jaut.2026.103563.